首页 | 官方网站   微博 | 高级检索  
     

瑞替普酶静脉溶栓治疗急性心肌梗死的疗效观察
引用本文:杨丽莉,王树源.瑞替普酶静脉溶栓治疗急性心肌梗死的疗效观察[J].热带医学杂志,2007,7(4):359-360.
作者姓名:杨丽莉  王树源
作者单位:1. 中铁五局三公司医院,肇庆,526021
2. 肇庆市第一人民医院,肇庆,526021
摘    要:目的观察瑞替普酶静脉溶栓治疗急性心肌梗死的疗效和安全性。方法30例患者均符合入选和不入选标准,予以瑞替普酶静脉溶栓治疗,观察血管再通的临床指标及不良反应。结果根据冠脉再通标准判断,30例患者血管再通构成比为76.7%,出血发生率为0.67%。结论急性心肌梗死患者选用瑞替普酶静脉溶栓是一种安全、有效的治疗方法。

关 键 词:瑞替普酶  急性心肌梗死  溶栓疗法
文章编号:1672-3619(2007)04-0359-02
修稿时间:2006-08-302006-10-25

Observation of Therapeutic Effect of Reteplase for Acute Myocardial Infarction
YANG Li-li,WANG Shu-yuan.Observation of Therapeutic Effect of Reteplase for Acute Myocardial Infarction[J].Journal Of Tropical Medicine,2007,7(4):359-360.
Authors:YANG Li-li  WANG Shu-yuan
Abstract:Objective To evaluate the efficacy and safety of reteplase for the treatment of acute myocardial infarction(AMI).Method Thirty patients with AMI were included in this study.The patients receiving venous thrombolysis with reteplase were then evaluated for reperfusion.Result After the treatment,the reperfusion rate was 79.6 %.0.67% of the patients had a mild bleeding.Conclusion Venous thrombolysis with reteplase is a safe and effective method for the treatment of patients with AMI.
Keywords:reteplase  acute myocardial infarction  thombolytic therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号